All Pharma articles – Page 29
-
NewsUK medicine prices 'cheapest in Europe'
The price of drugs is falling more steeply in the UK than the rest of Europe, it has been claimed.
-
NewsCalls to reduce 1.6m unnecessary prescriptions
Unnecessary prescriptions for antibiotics could be slashed by 1.6 million a year and save the NHS vital funds, researchers have said.
-
NewsNew consultation on pharmacy regulation proposed
A consultation exercise has been launched on proposed reform of the regulation system governing pharmacies across Great Britain.
-
HSJ KnowledgeHow improved medication adherence can prevent costly medicine waste
Preventing unnecessary hospital admissions for medication could save the NHS a significant part of the £150m “medicine waste” recognised in a Department of Health report, say Nina Barnett and Andrew McDowell.
-
Comment'Don't rush through regulation at the expense of innovation'
The PIP breast implant scandal has raised difficult questions for trusts and clinicians about the faith they place in the reliability of medical devices they use.
-
NewsFine hospitals restricting bowel cancer care, charity says
Hospitals that fail to offer bowel cancer patients a full range of appropriate treatments should be fined, a charity has said.
-
HSJ KnowledgeHow CCGs can make savings in their prescription budget
Providing GPs with the right support on prescribing can realistically deliver savings for CCGs in their prescription budgets that could make a significant dent in an annual NHS spend of £8bn a year, says Claire Forde.
-
NewsNew Medicine Service guidance released
New guidance has been published showing how the New Medicine Service and post discharge Medicines Use Reviews can be used to provide a seamless care pathway for patients who transfer from hospital to the community setting.
-
HSJ Local
Royal Liverpool submits planning application for BioInnovation centre
COMMERCIAL: The trust has submitted a planning application for a 70,000 sq ft Liverpool BioInnovation Centre, to provide commercial scale laboratory space to develop new treatments and medical technologies for the market.
-
NewsLansley vows to enforce drugs access rules
Legislation meant to end the variable access to drugs in NHS hospitals will be enforced, the health secretary has told the Commons.
-
HSJ KnowledgeUnderstanding non-compliance to improve patient behaviours
There are many myths about compliance in patient behaviour, writes Jane Shirely, so getting to the truth of the matter is important if rates of non-compliance and their costly consequences are to be reduced.
-
NewsClinical data regulation not robust, say experts
Leading doctors have called for an end to “incomplete data disclosure” and more robust regulation of information in clinical trials.
-
CommentMichael White: the eternal tension of national vs regional policy
David Cameron’s new plan to open up NHS medical records to high-tech life science researchers is a bit like chancellor George Osborne’s proposal in last week’s autumn statement to boost the regional economies in those parts of Britain that are suffering most in the downturn.
-
CommentMedia Watch: pensions play second fiddle patient privacy
The NHS has been all over the front pages during the past week or so, and not all of it to do with public sector strikes.
-
NewsPatient data 'assurances' needed for private sector data sharing - Burnham
Government plans to give NHS patients’ details to private firms developing new drugs must give “assurance” that privacy safeguards will be in place.
-
NewsPrivacy concerns over Cameron NHS data sharing plan
The prime minister David Cameron will today signal controversial moves to boost the economy by sharing NHS data with private healthcare companies.
-
HSJ Local
UHB to become 'magnet' for pharma money and clinical research after hook-up with uni
COMMERCIAL: University Hospitals Birmingham Foundation Trust and the University of Birmingham has today announced a joint working agreement to be known as Birmingham Health Partners (BHP).
-
NewsPharma suppliers put export ahead of NHS - Burns
Drugs for NHS patients are being delayed because suppliers make more money by selling medication to eurozone countries, the government has said.
-
NewsGuidance 'misconstrued' as commissioners restrict drugs
Primary care trusts are “misconstruing” official drugs guidance in order to restrict access to treatments, a coalition of patient bodies has warned.
-
HSJ Local
South West trusts sign pharma research deal
COMMERCIAL: Five NHS trusts have begun working with the world’s biggest biopharmaceutical company to provide patients for clinical trials.